Notably, EphA2-CAR-T cells were developed and tested on glioblastoma, where these cells recognized and suppressed EphA2-positive glioblastoma cells with significant reduction in in vivo tumor growth [126]. This evidence concerns the gene EPHA2 and neoplasm.